This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Central Garden & Pet (CENT) Posts Q4 Loss, Sales Decline Y/Y
by Zacks Equity Research
Central Garden & Pet's (CENT) Q4 results reflect softness in the garden segment and ongoing cost inflation. However, the company has been taking steps to strengthen its position.
Central Garden (CENT) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of -233.33% and 2.35%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Honest (HNST) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Honest (HNST) delivered earnings and revenue surprises of -62.50% and 0.13%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Party City (PRTY) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Party City (PRTY) delivered earnings and revenue surprises of -1,290% and 2.47%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Prestige Consumer Healthcare, Central Garden & Pet, Traeger and RealReal
by Zacks Equity Research
Prestige Consumer Healthcare, Central Garden & Pet, Traeger and RealReal have been highlighted in this Industry Outlook article.
Alto Ingredients (ALTO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alto Ingredients (ALTO) delivered earnings and revenue surprises of -866.67% and 2.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Consumer Products-Discretionary Stocks to Watch Amid Industry Headwinds
by Sumit Singh
Prestige Consumer Healthcare (PBH), Central Garden & Pet (CENT), Traeger (COOK) and The RealReal (REAL) have been focusing on superior product strategy and prudent capital investments.
Here's Why You Should Hold Central Garden & Pet (CENT) Stock
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition initiative constantly strengthens its portfolio. CENT is also steadily advancing its digital capabilities and focusing on marketing activities.
Central Garden & Pet's (CENT) Buyouts & E-Commerce Fuel Sales
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition initiative constantly strengthens its portfolio. CENT is also steadily advancing its digital capabilities and focusing on marketing activities.
Why Is Central Garden (CENT) Down 9.2% Since Last Earnings Report?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Central Garden & Pet (CENT) Beat on Earnings & Sales in Q3
by Zacks Equity Research
Central Garden & Pet's (CENT) Q3 results are affected by headwinds, including softness in the garden segment and ongoing cost inflation. However, the 'Central to Home' strategy bodes well.
Central Garden (CENT) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 10.32% and 2.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
What to Expect From Central Garden & Pet's (CENT) Q3 Earnings?
by Zacks Equity Research
Central Garden & Pet's (CENT) third-quarter fiscal 2022 earnings results are likely to reflect softness in the Garden portfolio.
Earnings Preview: Central Garden (CENT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Central Garden (CENT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Central Garden & Pet (CENT) Trims FY22 Earnings View
by Zacks Equity Research
Garden & Pet (CENT) cited unfavorable weather conditions, lower foot traffic and changing inventory expectations from customers behind sluggishness in the Garden segment.
Central Garden (CENT) Upgraded to Buy: Here's Why
by Zacks Equity Research
Central Garden (CENT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Prestige Consumer (PBH) Brand-Building Efforts Solid, Costs High
by Zacks Equity Research
Prestige Consumer (PBH) is benefiting from its solid brand-building efforts and growing e-commerce business.
Central Garden & Pet's (CENT) E-Commerce & Buyouts Fuel Sales
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition initiative constantly strengthens its portfolio. The company is also steadily advancing its digital capabilities and focusing on marketing activities.
Here's Why Hanesbrands (HBI) drops More Than 25% in 3 Months
by Zacks Equity Research
Hanesbrands (HBI) is grappling with higher inflation, which is affecting its margin performance. However, unfavorable foreign currency rates are a hurdle.
Central Garden (CENT) Up 3.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wall Street Analysts Predict a 30% Upside in Central Garden (CENT): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Central Garden (CENT) points to a 29.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe Central Garden (CENT) Could Rally 32%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Central Garden (CENT) points to a 31.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Spectrum Brands (SPB) Q2 Earnings and Sales Top Estimates
by Zacks Equity Research
Spectrum Brands' (SPB) Q2 sales gain from strength across segments and robust price realization, while dismal margins, owing to cost inflation and supply-chain headwinds, hurt earnings.
Central Garden & Pet (CENT) Q2 Earnings Beat, Sales Up Y/Y
by Zacks Equity Research
Central Garden & Pet Company's (CENT) second-quarter results reflect investments in digital capabilities and innovation as well as customer insights to drive growth.
Central Garden (CENT) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 7.63% and 2.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?